血浆分离卡在资源有限地区HIV耐药基因分型的性能:与血浆样本的比较
本研究比较血浆分离卡(PSC)与血浆样本在HIV耐药基因分型中的性能。从250名接受ART≥6个月且病毒载量≥1000 copies/mL的HIV感染者中选取配对样本,最终20对符合标准。PSC扩增成功率为19/20(95%),配对序列核苷酸相似度为98.5%(IQR 98.0%-99.3%),血浆中检出的37个主要耐药突变中PSC识别出35个(94.6%),仅1对存在临床显著不一致。结论认为PSC与血浆一致性良好,可作为资源有限地区HIV耐药基因分型的替代样本类型。
要点
- PSC样本HIV-1 Pol基因扩增成功率为95%(19/20)。
- PSC与血浆配对序列核苷酸相似度中位数98.5%。
- 主要耐药突变一致性94.6%,仅1对临床显著不一致。
核心结论
- PSC与血浆样本在HIV耐药基因分型中表现出良好一致性,有望作为资源有限地区临床实践和监测的替代样本类型。
研究设计与样本
- 从250名接受ART≥6个月且病毒载量≥1000 copies/mL的HIV感染者中选取配对血浆和PSC样本,最终20对符合纳入标准。
- HIV耐药基因分型采用CDC Atlanta内部方案,耐药解释使用Stanford HIVdb算法。
主要发现
- PSC样本HIV-1 Pol基因扩增成功率为19/20(95%)。
- 19对配对序列的核苷酸相似度为98.5%(IQR 98.0%-99.3%)。
- 血浆样本中检出37个主要耐药突变,PSC识别出35个(94.6%)一致突变。
- 4对样本的不一致仅限于混合碱基与单一碱基,未改变耐药分类;仅1对出现临床显著不一致(血浆检出K103N而PSC初始未检出)。
临床怎么用
- 在资源有限地区,可考虑使用PSC采集样本进行HIV耐药基因分型,以扩大远程地区的检测可及性。
局限性
- 最终分析仅纳入20对配对样本,样本量较小。
- 仅1对样本出现临床显著不一致,需更大样本验证PSC对特定突变的检测敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HIV drug resistance (HIVDR) threatens the effectiveness of antiretroviral therapy (ART) programmes in low- and middle-income countries. The Cobas Plasma Separation Card (PSC) is a recently developed specimen collection tool with potential to expand access to HIVDR genotyping in remote settings. This study evaluates PSC performance for HIVDR genotyping compared with plasma. METHODS: Paired plasma and PSC specimens were selected from 250 people living with HIV (PLHIV) on ART ≥6 months with viral load (VL) ≥1000 copies/mL. HIVDR genotyping followed CDC Atlanta in-house protocol; resistance interpretation used the Stanford HIVdb algorithm. Paired sequences were compared for subtype, nucleotide similarity, mutation profile and drug-resistance classification. RESULTS: Twenty paired specimens met inclusion criteria. Amplification of the HIV-1 Pol gene succeeded in 19/20 (95%) PSC samples. Of 19 paired sequences, nucleotide similarity was 98.5% (IQR 98.0%-99.3%). Eleven plasma samples showed 37 major drug-resistance mutations (MDM); 35 (94.6%) concordant MDM were identified in PSC. Discordances in four pairs were limited to mixed versus single bases and did not alter drug-resistance classification. Only one pair showed a clinically significant discordance (K103N detected in plasma but not initially in PSC). CONCLUSIONS: PSC demonstrated good concordance with plasma for HIVDR genotyping and has potential as an alternative specimen type for clinical practice and surveillance in resource-limited settings.
引用
- Pham TH, Ngo HTH, Pham TTP, et al. Performance of plasma separation cards for HIV drug-resistance genotyping in a resource-limited setting: comparison with plasma samples. J Antimicrob Chemother. 2026. PMID: 42615132. doi:10.1093/jac/dkag279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。